Baird keeps Outperform on Icon and Labcorp and raises both price targets
Baird lifted its price target on Icon to $249 and on Labcorp to $396, keeping Outperform ratings on both stocks. Source: TradingView.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Baird analysts kept Outperform ratings on Icon and Labcorp Holdings and raised their price targets. The Icon target rose from $210 to $249, an 18.6% increase. That level implies 16.3% upside from the October 28 close of $214.16. The Labcorp Holdings target moved from $361 to $396, a 9.7% increase, implying 9.9% upside from the October 28 close of $360.25.
The report was published by TradingView, with data provided by Benzinga.
why it matters
Target revisions reflect analysts' views rather than decisions by the companies themselves, and they usually have a limited effect on the shares. For investors, broader market direction and quarterly results matter more. A change in a target alone is not a recommendation to act.
tags
instruments
sources
- Baird maintains Icon at Outperform, raises price target to $249 from $210 — TradingView, 29 October 2026 at 11:26 UTC
- Baird maintains Labcorp Holdings at Outperform, raises price target to $396 from $361 — TradingView, 29 October 2026 at 11:39 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗